Results 81 to 90 of about 6,214,933 (159)

VP175 Validating Outcome Assessments For Health Technology Assessment In Ceroid Lipofuscinosis Neuronal 2 (CLN2), An Ultra-Rare Disease

open access: yes, 2017
INTRODUCTION:Ceroid lipofuscinosis neuronal 2 (CLN2) disease, a form of Batten disease, is a rare, degenerative neurometabolic disorder. Disease onset around 2–4 years is followed by rapid decline in motor and neurologic function and mortality in early ...
Andrea West   +7 more
core   +1 more source

Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse model

open access: yesThe Journal of Clinical Investigation, 2023
Although a disease-modifying therapy for classic late infantile neuronal ceroid lipofuscinosis (CLN2 disease) exists, poor understanding of cellular pathophysiology has hampered the development of more effective and persistent therapies.
Keigo Takahashi   +10 more
doaj   +1 more source

Case Report: The window that closed too soon: lessons from a late CLN2 diagnosis and death of a 9-year-old boy

open access: yesFrontiers in Genetics
A class of progressive, autosomal recessive neurodegenerative diseases known as neuronal ceroid lipofuscinoses (NCLs) are brought on by lysosomal protein or enzyme dysfunction.
Anna Bryzik   +4 more
doaj   +1 more source

Two-year follow-up of gait and postural control following initiation of recombinant human tripeptidyl intracerebroventricular enzyme replacement therapy in two atypical CLN2 patients

open access: yesScientific Reports
Neuronal ceroid lipofuscinosis type 2 (CLN2) is a rapidly progressive neurodegenerative disorder leading to premature mortality. Ambulatory CLN2 patients typically receive standard of care treatment through biweekly intracerebroventricular (ICV) enzyme ...
Rahul Soangra   +3 more
doaj   +1 more source

Flupirtine derivatives as potential treatment for the neuronal ceroid lipofuscinoses

open access: yesAnnals of Clinical and Translational Neurology, 2018
Objective Neuronal Ceroid Lipofuscinoses (NCL) are fatal inherited neurodegenerative diseases with established neuronal cell death and increased ceramide levels in brain, hence, a need for disease‐modifying drug candidates, with potential to enhance ...
Joelle Makoukji   +7 more
doaj   +1 more source

A current view of mitochondria damage and the diversity of lipopigment inclusions in neuronal ceroid lipofuscinose type 2 from rectal biopsy

open access: yesFolia Neuropathologica
Neuronal ceroid lipofuscinoses (NCLs) are a growing group of neurodegenerative storage diseases, in which specific features are sought to facilitate the creation of a universal diagnostic algorithm in the future. In our ultrastructural studies, the group
Paulina Felczak   +5 more
doaj   +1 more source

Evolution of Movement Disorders in Patients With CLN2-Batten Disease Treated With Enzyme Replacement Therapy [PDF]

open access: yes
OBJECTIVES: Neuronal ceroid lipofuscinosis type 2 (CLN2-disease) is an inherited childhood-onset neurodegenerative condition, with classical early features of speech delay, epilepsy, myoclonus, ataxia, and motor regression.
Soo, Audrey K   +8 more
core   +1 more source

The Challenges of Living with and Caring for a Child or Children Affected by Neuronal Ceroid Lipofuscinosis Type 2 Disease: In-Depth Family Surveys in the United Kingdom and Germany

open access: yesJournal of Inborn Errors of Metabolism and Screening
Limited research has investigated the challenges faced by families caring for children with neuronal ceroid lipofuscinosis type 2 (CLN2) disease. Face-to-face, mixed-method, in-depth surveys were conducted with 19 families (23 children) in the UK (n=9 ...
Angela Schulz   +10 more
doaj   +1 more source

G1-faasi tsükliinist sõltuva kinaasi kompleksi Cln2-Cdk1 substraatide valiku mehhanismid [PDF]

open access: yes, 2016
Saccharomyces cerevisiae Cdk1 reguleerib erinevate valkude fosforüleerimise kaudu kogu rakutsükli toimimist. Eri aegadel seondub Cdk1 erinevate tsükliinidega. Mitmed Cdk1 substraadid on enim fosforüleeritud G1-faasis, mil Cdk1 on kompleksis tsükliiniga
Örd, Mihkel
core  

Speech, Language and Non‐verbal Communication in CLN2 and CLN3 Batten Disease

open access: yesJournal of Inherited Metabolic Disease
ABSTRACT CLN2 and CLN3 diseases, the most common types of Batten disease (also known as neuronal ceroid lipofuscinosis), are childhood dementias associated with progressive loss of speech, language and feeding skills.
Lottie D. Morison   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy